PatientsVille.com Logo

ABDOMINAL PAIN and Atenolol

PatientsVille

ABDOMINAL PAIN Symptoms and Causes

Your abdomen extends from below your chest to your groin. Some people call it the stomach, but your abdomen contains many other important organs. Pain in the abdomen can come from any one of them. The pain may start somewhere else, such as your chest. Severe pain doesn't always mean a serious problem. Nor does mild pain mean a problem is not serious.

Call your health care provider if mild pain lasts a week or more or if you have pain with other symptoms. Get medical help immediately if

  • You have abdominal pain that is sudden and sharp
  • You also have pain in your chest, neck or shoulder
  • You're vomiting blood or have blood in your stool
  • Your abdomen is stiff, hard and tender to touch
  • You can't move your bowels, especially if you're also vomiting

Check out the latest treatments for ABDOMINAL PAIN

ABDOMINAL PAIN treatment research studies

Atenolol clinical trials, surveys and public health registries


Find Drug Side Effect reports



Atenolol Side Effects

Bradycardia (333)
Dizziness (236)
Hypotension (218)
Completed Suicide (205)
Dyspnoea (180)
Nausea (171)
Blood Pressure Increased (150)
Syncope (145)
Hypertension (141)
Asthenia (141)
Fatigue (124)
Diarrhoea (124)
Headache (118)
Pain (115)
Malaise (110)
Toxicity To Various Agents (108)
Chest Pain (107)
Fall (98)
Palpitations (93)
Cerebrovascular Accident (89)
Vomiting (87)
Insomnia (81)
Myocardial Infarction (79)
Anxiety (78)
Oedema Peripheral (76)
Off Label Use (75)
Depression (75)
Pruritus (74)
Feeling Abnormal (73)
Back Pain (69)
Pain In Extremity (67)
Renal Failure Acute (66)
Abdominal Pain (66)
Arthralgia (66)
Weight Decreased (63)
Cough (62)
Heart Rate Increased (58)
Muscle Spasms (58)
Rash (58)
Blood Creatinine Increased (57)
Pneumonia (54)
Hyperkalaemia (54)
Loss Of Consciousness (53)
Overdose (53)
Weight Increased (53)
Hyperhidrosis (52)
Blood Cholesterol Increased (51)
Heart Rate Decreased (50)
Renal Failure (50)
Somnolence (50)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

When I eat or drink this burning feeling in my chest going up like I am about vomiting.what is happening? And something I and chest pain too! And I am 14 and a girl

8-)Have been taking atenolol and lisinipril for about 6 years, and before now did not realize the extreme itchiness in toes and fingers that started at first and now has turned in very cold and numb toes and feet and getting worse. I now believe it

A 40-year-old manager, at a prominent legal firm in L.A., experiences abdominal pain post lunch. He goes to the restroom a couple of times, but continues to experience pain and cramps. He eventually decides to get himself examined. While questioning

Anxiety, Paranoia, Arrythmia

Before I took atenolol i had a perfect glucose numbers after taking it I came down with diabetes. I am 102lbs, 4'11, have always eaten healthy, exercise my whole life. I am 76. I was taken off atenolol after5 years...and NO ONE in my family for ge

Buenas quisiera saber si venden el medicamento rapamude o sirolimus en jarabe de 120 ml quisiera saber el costo,espero pronta respuesta muchas gracias

Congested chest

Dehydration causes uterine contractions which causes cramping. you should drink more water!

Every since i had my 3 years old daugther my periods hasnt been the same. I would go twice a month for 5 or 7 days. I will have pains in stomach stays there then only hurts on the half side goes in my lower back. Can anybody help me?

For the past week or two ive been feeling shooting pains on my bottom left side and been experiencing a shrp pain shooting from my chest towards my heart,were in most cases I have to apply preasure fore it to go away.I can hardly sleep when I lay on

I took Beano (only one pill) last week and 2 hours later I ended up with a terrible stomach pain.I did not connect the dots, I suspected that it was caused by certain ingredients in the food I was eating. Itwas a very unique pain

Yesterday, after taking Sam-e with Glucosamine. I got a pain between my shoulder blade, jaw pain, dizziness, sweating. felt like a heart attack. I did not go to the hospital because of the money needed. No ins

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

63 yo man received Zostavax injection in the left upper arm 12/13/11. Developed painful blister on the right shoulder and pain at the right lower ribs 12/10/11.

After using Clobetasol for a two week cycle, my doctor suggested I use it one day during the week, applying it twice that day. Since that time, I have experinced severe chest pain. I recently saw my doctor for heart attack symptoms before I reali

Arthritis Treatment Safe, Natural Cure for Adults. Synflex Liquid Glucosamine, Rheumatoid Arthritis Joint Pain Relief Remedy, Diet Supplements. Synflex, Glucosamine for Dogs. Free Shipping! &lt;a href='http://www.healthyjointcare.com/'&g

My father is 68 and retired, he is also diabetic. He suffers from severe joints, hip and back pain. He has been using panadol extra strength but finds it takes too long to act. He is also allergic to aspirin and was hospitalized with a ruptured u

While taking Pradaxa I had severe knife feeling pain in left eye. I have been off 2 days and it is better. I will check with eye docotr this week and see if it is eye or meds.

Yes I am Aspavor 20mg and also have a back pain were I am constantly taking pain killers. I actually thought that I did some thing wrong by lifting but just from sitting or turning my body it will return it starts to effect my job off shore and h

i feel nick pain & headache i am ussed 9th month

ABDOMINAL PAIN Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.
Condition: Chronic Stable Angina
Interventions: Drug: Nicorandil;   Drug: Atenolol
Outcome Measures: SPECT Tc99m- Tetrofosmin (MYOVIEW);   Exercise ECG Testing - Bruce protocol
2 Recruiting Comparison Study of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol
Condition: Marfan Syndrome
Interventions: Drug: Aliskiren;   Drug: Atenolol
Outcome Measures: Central aortic PWV(pulsed wave velocity);   Central aortic distensibility by MRI at week 24
3 Recruiting A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function
Condition: Hypertension
Interventions: Drug: Nebivolol;   Drug: Atenolol;   Drug: placebo
Outcome Measures: Comparing effects of nebivolol against Atenolol and placebo on endothelial function;   Evaluate effects of nebivolol as compared to Atenolol and placebo
4 Recruiting Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Drug: Atenolol
Outcome Measure: Ventricular rate response during exercise.
5 Recruiting Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients
Condition: Hypertension
Interventions: Drug: Fimasartan;   Drug: Atenolol
Outcome Measures: The difference of sitting Systolic Blood Pressure(SiSBP) between at the peak compared to at resting;   The difference of sitting Diastolic Blood Pressure(SiDBP) at the peak compared to at resting;   The difference of sitting Systolic Blood Pressure(SiSBP) at each exercising stage compared to at resting;   The difference of sitting Systolic Blood Pressure(SiSBP) among at resting, each exercising stage and recovery
6 Recruiting Hemodynamic Changes of Patients Receiving Atenolol/Bisoprolol
Conditions: Hypertension;   Metabolic Syndrome
Interventions: Drug: Atenolol;   Drug: Bisoprolol
Outcome Measures: central blood pressure;   peripheral resistance;   cardiac index;   pulse wave velocity
7 Recruiting Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)
Condition: Cardiac Disease
Interventions: Drug: Atenolol;   Drug: Telmisartan
Outcome Measures: Change from baseline in ascending aorta size, as evaluated by MRI;   Rate of change in ascending aorta size evaluated by transthoracic echocardiography (TEE).
8 Unknown  Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Atenolol
Outcome Measures: Change in diastolic function (annular tissue velocity [Em]);   Change in free fatty acid kinetics;   Change in insulin sensitivity, glucose effectiveness, glucose, insulin, high-density lipoprotein (HDL), or triglycerides
9 Unknown  A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Losartan and Atenolol or Propranolol;   Drug: Atenolol or Propranolol
Outcome Measure: Echocardiograms
10 Recruiting Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones
Condition: Healthy
Interventions: Drug: Saline;   Drug: Glucagon;   Drug: Placebo;   Drug: Atenolol
Outcome Measures: Circulating acyl-ghrelin concentration after glucagon stimulation with and without beta-adrenergic blockade;   Association between circulating acyl-ghrelin concentration and GH and cortisol after glucagon administration with and without beta-adrenergic blockade
11 Recruiting Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study
Condition: Hypertension
Intervention: Drug: Lisinopril, Atenolol
Outcome Measure: One type of blood pressure medication will better treat individuals with certain genetic backgrounds.
12 Recruiting Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm
Condition: Small Abdominal Aortic Aneurysm
Interventions: Drug: Beta-blocker-Atenolol 50mg, PO(peroral), Once daily;   Drug: Angiotensin receptor blocker-Valsartan 80mg, PO(peroral), Once daily
Outcome Measure: Annual aneurysm growth of abdominal aortic aneurysm
13 Not yet recruiting Single Pill to Avert Cardiovascular Events
Condition: Cardiovascular Disease
Interventions: Drug: polipillV1;   Drug: polipillV2;   Drug: usual care
Outcome Measures: compliance with treatment;   changed in blood pressure;   changes in LDL-cholesterol levels;   the main reason for non compliance with treatment;   safety of poli pill measures by laboratorial tests;   combined outcome
14 Recruiting Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Cardiovascular Risk Assessment
Conditions: Essential Hypertension;   Cardiovascular Disease;   Stroke;   Chronic Kidney Disease
Interventions: Drug: Any antihypertensive medication alone or in combination;   Device: Ambulatory blood pressure monitoring
Outcome Measures: To evaluate the impact of circadian time of treatment in cardiovascular, cerebrovascular and renal risk assessment.;   To evaluate the influence of circadian time of treatment in BP control of hypertensive patients.;   To evaluate the prevalence of an altered (non-dipper) BP profile in patients with resistant hypertension as a function of the circadian time of treatment.;   To evaluate the influence of diabetes and circadian time of treatment in the prevalence of an altered (non-dipper) BP profile.;   To evaluate the influence of age and circadian time of treatment in the prevalence of an altered (non-dipper) BP profile.;   To evaluate, for all groups of interest, the prevalence and cardiovascular risk profile of white-coat hypertension.;   To evaluate, for all groups of interest, the prevalence and cardiovascular risk profile of masked hypertension.;   To evaluate, for all previous objectives, potential differences between men and women.;   To evaluate the impact of changes in ambulatory BP in cardiovascular, cerebrovascular and renal risk assessment.
15 Recruiting Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
Condition: Atrial Fibrillation
Intervention: Other: Aggressive Blood Pressure control
Outcome Measures: Time to recurrent Atrial fibrillation;   Recurrence of AF at one year
16 Unknown  Heart Rate Reduction in Heart Failure
Condition: Heart Failure
Interventions: Drug: ivabradine;   Drug: Carvedilol/Ivabradine;   Drug: Carvedilol
Outcome Measures: Exercise tolerance assessed by 6 minute walking test;   Quality of life
17 Unknown  Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study
Conditions: Hypertension;   Diabetes;   Death From Cardiovascular Disease;   Myocardial Infarction;   Stroke
Intervention:
Outcome Measures: Number of participants who have died from cardiovascular disease and the number who have suffered a non-fatal myocardial infarction (MI) and/or non-fatal stroke since the end of the ASCOT study;   Number of participants who have developed diabetes since the end of the ASCOT trial;   Number of participants who have undergone coronary/peripheral re-vascularisation procedures since the end of the ASCOT trial;   Number of participants who have required renal replacement therapy (dialysis or kidney transplant) since the end of the ASCOT trial;   Number of participants who have experienced a transient ischaemic attack since the end of the ASCOT trial
18 Recruiting The International Polycap Study 3 (TIPS-3)
Conditions: Cardiovascular Disease;   Fractures;   Cancers
Interventions: Drug: Polycap DS;   Drug: enteric coated aspirin;   Drug: cholecalciferol
Outcome Measures: Composite of major CVD (CV death, non-fatal stroke, non-fatal MI), plus heart failure, resuscitated cardiac arrest, or revascularization with evidence of ischemia in participants taking Polycap versus placebo;   Composite of CV events (CV death, MI or stroke) and cancer in participants taking aspirin versus placebo;   Risk of fractures in participants taking vitamin D versus placebo;   Composite of CV death, non-fatal stroke, and nonfatal MI in participants taking Polycap versus placebo;   Composite outcome of CV events and cancers after 10 years of follow up in participants taking aspirin versus placebo;   Composite outcome of CV events, fractures and cancers, and the risk of the falls at 10 years of follow up in participants taking vitamin D versus placebo
19 Recruiting Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Conditions: Atrial Fibrillation;   Arrhythmia
Interventions: Device: Left atrial ablation;   Drug: Rate or Rhythm Control Therapy
Outcome Measures: LA catheter ablation is superior to rate or rhythm control drug therapy for decreasing the incidence of the composite endpoint of total mortality, disabling stroke, serious bleeding, or cardiac arrest in patients warranting therapy for AF.;   LA catheter ablation is superior to rate or rhythm control drug therapy for reducing total mortality;   Total mortality or cardiovascular hospitalization;   Cardiovascular death;   Cardiovascular death or disabling stroke;   Arrhythmic death or cardiac arrest;   Heart failure death;   Freedom from recurrent AF;   Cardiovascular hospitalization;   Medical costs, resource utilization, and cost effectiveness;   Quality of Life;   Composite adverse events;   Left atrial size, morphology and function and its relationship to morbidity and mortality